Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

FDA and EMA accept Bristol-Myers’ filing for expanded Opdivo indications The US Food and Drug Administration (FDA) and the European Medicines Agency have accepted to review Bristol-Myers Squibb’s market applications seeking approval to expand the use of Opdivo for patients with previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Production & Manufacturing > Process & Production > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
Production & Manufacturing > Fine & Speciality Chemicals > News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News

Process & Production

Janssen Biotech files US regulatory application for Sirukumab in rheumatoid arthritis
By PBR Staff Writer
Janssen Biotech is seeking approval for sirukumab in the US to treat adults with moderately to severely active rheumatoid arthritis (RA).
Production & Manufacturing > Process & Production > News
EMA’s CHMP recommends approval for three new cancer drugs
By PBR Staff Writer
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended three cancer drugs for approval.
Production & Manufacturing > Process & Production > News

OTC

Ember Therapeutics to buy Dermasilk Brands
Ember Therapeutics has agreed to acquire Dermasilk Brands, a commercially available over-the-counter beauty product portfolio encompassing fourteen different products.
Production & Manufacturing > OTC > News
Crescita Therapeutics acquires INTEGA Skin Sciences
Crescita Therapeutics has acquired INTEGA Skin Sciences, a Montreal-based dermatology company which develops, manufactures, sells and markets science-based quality skin care products.
Production & Manufacturing > OTC > News

Manufacturing

Pharmaron enters into non-binding heads of terms with MSD over Hoddesdon UK site
Pharmaron has entered into a non-binding Heads of Terms (HoTs) with Merck Sharp & Dohme Limited (MSD) for the sale of the Hoddesdon UK site which includes MSD’s process development and research facility.
Production & Manufacturing > Manufacturing > News
GSK names Emma Walmsley as new CEO
GlaxoSmithKline (GSK) has named Emma Walmsley as its new chief executive officer (CEO).
Production & Manufacturing > Manufacturing > News